Skip to main content

Lisa DeFrancesco

Head of Investor Relations

Amarin Corp Plcuk (AMRN)

Head of Investor Relations

Lexicon Pharmaceuticals, Inc. (LXRX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Amarin Corp Plcuk publishes a filing, an earnings call transcript or a press release.

Get AMRN alerts

About Lisa DeFrancesco

Lisa DeFrancesco is recorded as Head of Investor Relations at Amarin Corp Plcuk (AMRN) and Head of Investor Relations at Lexicon Pharmaceuticals, Inc. (LXRX). Lisa DeFrancesco has spoken on 14 earnings calls across 2 companies, most recently for Lexicon Pharmaceuticals, Inc. on November 5, 2026. Those appearances were for Lexicon Pharmaceuticals, Inc. (LXRX) and Amarin Corp Plcuk (AMRN). Lexicon Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Amarin Corp Plcuk is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Lexicon Pharmaceuticals, Inc. includes Michael Exton, Ph.D. (CEO and Board Member), Michael S. Exton (CEO and Board Member), Raymond Debbane (Chairman) and 7 others.

Lisa DeFrancesco on recent calls

“Joining me today are Dr. Mike Exson, Lexicon's Chief Executive Officer and Director, Dr. Craig Granowitz, Senior Vice President and Chief Medical Officer, and Scott Chianti, Senior Vice President and Chief Financial Officer.”
Head of Investor Relations, Lexicon Pharmaceuticals, Inc. Q3 FY2026 Earnings Call ·
“Joining me today are Dr. Mike Exson, Lexicon's Chief Executive Officer and Director, Dr. Craig Granowitz, Senior Vice President and Chief Medical Officer, and Scott Chianti, Senior Vice President and Chief Financial Officer.”
Head of Investor Relations, Lexicon Pharmaceuticals, Inc. Q2 FY2026 Earnings Call ·
“Joining me today are Dr. Mike Exton, Lexicon's Chief Executive Officer and Director, Dr. Craig Granowitz, Senior Vice President and Chief Medical Officer, and Scott Chianti, Senior Vice President and Chief Financial Officer.”
Head of Investor Relations, Lexicon Pharmaceuticals, Inc. Q1 FY2026 Earnings Call ·
“Joining me today are Dr. Mike Exton, Lexicon's Chief Executive Officer and Director, Dr. Craig Granowitz, Senior Vice President and Chief Medical Officer, and Scott Chianti, Senior Vice President and Chief Financial Officer.”
Head of Investor Relations, Lexicon Pharmaceuticals, Inc. Q4 FY2025 Earnings Call ·
“Joining me today are Dr. Mike Exson, Lexicon's Chief Executive Officer and Director, Dr. Craig Granowitz, Senior Vice President and Chief Medical Officer, and Scott Chianti, Senior Vice President and Chief Financial Officer.”
Head of Investor Relations, Lexicon Pharmaceuticals, Inc. Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Lexicon Pharmaceuticals, Inc.

Leadership on record at Amarin Corp Plcuk

Recent activity

Show 2 earlier activities